SAN ANTONIO--(BUSINESS WIRE)--The Board of Directors of the parent company of Kinetic Concepts, Inc. and LifeCell Corporation is pleased to announce that Timothy E. Guertin has agreed with the parent company’s financial sponsors to join the Board of Directors.
Mr. Guertin has been involved in the healthcare industry for over 35 years. He is the former president and chief executive officer of Varian Medical Systems, Inc. During his career at Varian Medical Systems, Mr. Guertin served in several key management positions, including as Chief Operating Officer from October 2004 to February 2006 and as Corporate Executive Vice President from October 2002 to August 2006. Prior to that time, he was President of Varian’s Oncology Systems business unit from 1992 to January 2005 and a Corporate Vice President from 1992 to 2002. Mr. Guertin is also a member of the board of directors of Varian Medical Systems, Inc. and Teradyne, Inc. In addition, Mr. Guertin sits on the board of the Radiation Oncology Institute, an education and research organization dedicated to advancing the use and effectiveness of radiotherapy.
“Tim Guertin’s significant prior experience in leading a global medical technology company will be an outstanding addition to our Board,” said Buddy Gumina, Partner and co-head, Apax Healthcare Team. “We are delighted that Tim has agreed to join the Board of Directors and look forward to his involvement in strategy and oversight of the KCI and LifeCell companies.”
The parent company of Kinetic Concepts, Inc. and LifeCell Corporation is controlled indirectly by investment funds advised by Apax Partners, Canada Pension Plan Investment Board, and the Public Sector Pension Investment Board.
Kinetic Concepts, Inc. is a leading global medical technology company devoted to understanding, developing and commercializing innovative, high-technology Transformational Healing solutions for customers and patients in more than 20 countries around the world. Headquartered in San Antonio, Texas, KCI is committed to advancing the science of healing and positively impacting patient care by developing customer-driven innovation to meet the evolving needs of healthcare professionals. Proprietary KCI negative pressure technologies have revolutionized the way in which caregivers treat a wide variety of wound types. The V.A.C.® Therapy System has been used on approximately 7 million wounds worldwide. Additional information about KCI and its products is available at www.KCI1.com.
LifeCell Corporation, based in Bridgewater, NJ, is a leader in regenerative medicine, develops and markets innovative tissue repair products for the reconstructive, orthopedic and urogynecologic biosurgery markets. LifeCell™ products include Strattice™ Reconstructive Tissue Matrix and AlloDerm® Regenerative Tissue Matrix for plastic, reconstructive, and general surgical applications; Cymetra® Regenerative Tissue Matrix, a particulate form of AlloDerm® Tissue Matrix suitable for injection; Repliform® Regenerative Tissue Matrix for urogynecologic surgical procedures; GraftJacket® and Conexa™ for orthopedic surgical procedures; and the SPY® Elite System for the visualization and evaluation of tissue perfusion. Additional information about LifeCell and its products is available at www.LifeCell.com.